Predictors of response to venetoclax and therapeutic potential of CDK7 inhibition in multiple myeloma.

Blood Neoplasia · 2024 · PMC12182838 · PMID 40552134

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceP = .07so close (0.05 < p ≤ 0.1)

a trend toward significanceno p-value reported

Gain of 1q portends poor outcomes in patients with t(11;14) treated with venetoclax Univariate analysis using Kaplan-Meier and log-rank tests revealed a trend toward significance for the association of t(11;14) with longer PFS, although the difference did not reach statistical significance ( P = .07; Figure 1 A).

also in 3,729 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.